000			01369 a2200385 4500
005			20250516060655.0
264		0	_c20120110
008			201201s 0 0 eng d
022			_a1179-1950
024	7		_a10.2165/11596240-000000000-00000 _2doi
040			_aNLM _beng _cNLM
100	1		_aMakol, Ashima
245	0	0	_aRheumatoid arthritis and pregnancy: safety considerations in pharmacological management. _h[electronic resource]
260			_bDrugs _cOct 2011
300			_a1973-87 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntirheumatic Agents _xadverse effects
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aBreast Feeding
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLactation _xdrug effects
650	0	4	_aPostpartum Period
650	0	4	_aPreconception Care
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications _xdrug therapy
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
700	1		_aWright, Kerry
700	1		_aAmin, Shreyasee
773	0		_tDrugs _gvol. 71 _gno. 15 _gp. 1973-87
856	4	0	_uhttps://doi.org/10.2165/11596240-000000000-00000 _zAvailable from publisher's website
999			_c21219006 _d21219006